12482795

Source:http://linkedlifedata.com/resource/pubmed/id/12482795

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011071, umls-concept:C0302350, umls-concept:C0679199, umls-concept:C1521970, umls-concept:C1631597, umls-concept:C2698651
pubmed:issue	1
pubmed:dateCreated	2002-12-16
pubmed:abstractText	To investigate the clinical outcome, ECG characteristics, and optimal treatment of catecholaminergic polymorphic ventricular tachycardia (CPVT), a malignant and rare ventricular tachycardia.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-10097181, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-10588221, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-10790202, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-10899057, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-11157710, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-11208676, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-1138739, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-1309182, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-14297264, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-14448857, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-1713558, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-1994792, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-2816749, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-3045477, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-5721307, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-6126359, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-7626354, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-7867192, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-7900661, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-7951245, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-8269305, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-8281648, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-8589694, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-8824801, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-9106603, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-920265, http://linkedlifedata.com/resource/pubmed/commentcorrection/12482795-9344647
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9602087
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Anti-Arrhythmia Agents, http://linkedlifedata.com/resource/pubmed/chemical/Catecholamines, http://linkedlifedata.com/resource/pubmed/chemical/Verapamil
pubmed:status	MEDLINE
pubmed:month	Jan
pubmed:issn	1468-201X
pubmed:author	pubmed-author:AragakiYY, pubmed-author:HaradaKK, pubmed-author:HayakawaSS, pubmed-author:JouoKK, pubmed-author:KonishiSS, pubmed-author:KoujiroMM, pubmed-author:KurosakiKK, pubmed-author:MatsuokaSS, pubmed-author:MiuraMM, pubmed-author:NagashimaMM, pubmed-author:NakamuraYY, pubmed-author:NiimuraII, pubmed-author:OonoTT, pubmed-author:SaitoAA, pubmed-author:ShibataTT, pubmed-author:SumitomoNN, pubmed-author:UshinohamaHH, pubmed-author:YasudaTT
pubmed:issnType	Electronic
pubmed:volume	89
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	66-70
pubmed:dateRevised	2009-11-18
pubmed:meshHeading	pubmed-meshheading:12482795-Adolescent, pubmed-meshheading:12482795-Adrenergic beta-Antagonists, pubmed-meshheading:12482795-Adult, pubmed-meshheading:12482795-Anti-Arrhythmia Agents, pubmed-meshheading:12482795-Catecholamines, pubmed-meshheading:12482795-Catheter Ablation, pubmed-meshheading:12482795-Child, pubmed-meshheading:12482795-Child, Preschool, pubmed-meshheading:12482795-Death, Sudden, Cardiac, pubmed-meshheading:12482795-Echocardiography, pubmed-meshheading:12482795-Electrocardiography, pubmed-meshheading:12482795-Female, pubmed-meshheading:12482795-Heart Rate, pubmed-meshheading:12482795-Humans, pubmed-meshheading:12482795-Male, pubmed-meshheading:12482795-Polymorphism, Genetic, pubmed-meshheading:12482795-Survival Rate, pubmed-meshheading:12482795-Tachycardia, Ventricular, pubmed-meshheading:12482795-Treatment Outcome, pubmed-meshheading:12482795-Verapamil
pubmed:year	2003
pubmed:articleTitle	Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death.
pubmed:affiliation	Department of Paediatrics, Nihon University School of Medicine, Itabashi, Tokyo, Japan. jt9n-smtm@asahi-net.or.jp
pubmed:publicationType	Journal Article